Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed
NICX(NICX) Attachment
September 4, 2025Financing
Read more →Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients
NICXAttachment
August 21, 2025Clinical Trials
Read more →Nicox Extends Existing Flexible Equity Financing
NICXAugust 8, 2025Financing
Read more →